BIRD
BINAstoria
Science
Education
News
Partners
Congresses & Events
Become a member
Contact
Login
BIRD
About
Structure
Modus Operandi
BINAstoria
About
Projects
Science
Studies
BIRD registry
BIRD Biobank
BIRD Grants
Documents
Publications
Education
Projects
E-learning
Congress Presentations
Documents
Videos
News
Announcements
News
Linkedin
X - Bird
Congresses & Events
Annual Congress
IUS Workshop
Agenda
General Assemblies
info@birdgroup.be
Patients
Become a member
Contact
Login
BIRD
About
Structure
Modus Operandi
BINAstoria
About
Projects
Science
Studies
BIRD registry
BIRD Biobank
BIRD Grants
Documents
Publications
Education
Projects
E-learning
Congress Presentations
Documents
Videos
News
Announcements
News
Linkedin
X - Bird
Partners
Congresses & Events
Annual Congress
IUS Workshop
Agenda
General Assemblies
Research papers
BIRD
Other
The Lancet, Volume 404, Issue 10470, 2423 - 2436
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease
Read more
The Lancet Gastroenterology & Hepatology, online November 18, 2024, https://doi.org/10.1016/S2468-1253(24)00317-0
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
Read more
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_2, October 2024, Pages ii55–ii66
Framework of IBD Care Delivery Across Ages
Read more
Gastroenterology, Volume 166, Issue 3, 521 - 532
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review
Read more
Gastroenterology. 2024 Jun;166(6):949-956. doi: 10.1053/j.gastro.2024.02.016. Epub 2024 Feb 18. PMID: 38378092.
Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery
Read more
N Engl J Med . 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
Read more
Lancet Gastroenterol Hepatol. 2024 June vol 9, issue 6, p521-538
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
Read more
Clin Gastroenterol Hepatol . 2024 May 22:S1542-3565(24)00492-0. doi: 10.1016/j.cgh.2024.05.017
RIGOROUS DONOR SELECTION FOR FMT IN ACTIVE ULCERATIVE COLITIS: KEY LESSONS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY
Read more
‹
1
2
3
4
›
Username *
Password *